Barclays Capital reiterated Healthsouth Corporation (NYSE: HLS) to Overweight with price target $29
Barclays Capital reiterated Healthsouth Corporation (NYSE: HLS) to Overweight with price
target $29. Barclays Capital rated Healthsouth Corporation (NYSE: HLS) to Overweight with price target $27 on 01/25/2011, when the price was $22.75.
HealthSouth Corporation (HealthSouth) is a provider of inpatient rehabilitative healthcare services. The Company operates 93 inpatient rehabilitation hospitals, six freestanding long-term acute care hospitals (LTCHs), 49 outpatient rehabilitation satellites (operated by its hospitals), and 25 licensed, hospital-based home health agencies. Its outpatient rehabilitation facilities offer a range of rehabilitative healthcare services, including physical, occupational and speech therapies treating a range of neurological and orthopedic conditions. LTCHs provide medical treatment to patients with chronic diseases and/or complex medical conditions. In August 2008, the Company acquired an inpatient rehabilitation unit at the Medical Center of Arlington in Texas. In August 2008, it acquired an inpatient rehabilitation hospital in Midland, Texas from Rehabcare Corporation. On July 31, 2008, it acquired The Rehabilitation Hospital of South Jersey.
has assembled a world-class, award-winning team of analysts covering, credit, commodities, economics, emerging markets, equities, fixed income, foreign exchange and market strategy.
We provide in-depth analysis of companies and macro coverage across asset classes, markets and the world’s economies. We have a highly quantitative approach and our research is underpinned by sophisticated analytics. Combined, these provide clients with the tools and insights necessary for successful risk management and financing.
Our research teams are based in many of the world’s major financial centres providing our clients with a globally integrated perspective across products and geographies.